Owns and operates ambulatory surgery centers and surgical hospitals performing outpatient procedures across specialties.
Owns and operates ambulatory surgery centers and surgical hospitals performing outpatient procedures across specialties.
Is paid facility fees by insurers and Medicare for each procedure, while surgeons bill separately, and its centers are jointly owned with local physicians who hold minority stakes. Case volumes and insurer rate negotiations drive results. Private-equity firm Bain Capital is its largest shareholder.
Moat: narrow (scale, regulatory licence). Physician-partnership model and facility licensing create switching costs versus building new centers.
Headquarters: Brentwood, Tennessee, United States · Founded: 2004 · Employees: 16,000
Size Surgery Partners (SGRY) is a United States Health Care company (Hospital/Nursing Management) with a market value of $3.53B, the 1422nd largest of 3,085 United States companies the cockpit tracks. Shares closed at $26.96 on 18 Nov 2026.
Performance Over six months the shares gained 99.8%, against -0.9% for the median peer and -2.2% for the United States market (cap-weighted) — highest of 21 in its peer set.
Growth Revenue grew 2.2% over the last twelve months (peer median +12.9%); the operating margin is 12.8% (peer median 9.4%).
Valuation It trades at 77.2× forward earnings against a peer median of 37.3× (5th most expensive of 19).
Price implies For today's price to make sense, revenue must grow about 16% a year for seven years (Req g). Recent delivered growth is +12%, so the hurdle is +3 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 4.9 points below its cost of capital (10.1% WACC).
Short interest Short interest is 7.0% of the free float (30 Oct 2026).
Next results Next results expected around 1 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $3.36B | $3.31B | $3.11B | $2.74B | $2.54B |
| Revenue growth | — | +6% | +14% | +8% | — |
| Gross profit | $570M | $589M | $593M | $529M | $460M |
| EBITDA | $608M | $647M | $608M | $527M | $508M |
| Net income | -$87.0M | -$77.9M | -$168M | -$11.9M | -$54.6M |
| Free cash flow | $203M | $196M | $210M | $205M | $78.2M |
| Capital expenditure | $75.1M | $78.7M | $90.4M | $88.8M | $80.6M |
| Total debt | $3.31B | $4.02B | $3.70B | $3.06B | $2.93B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Surgery Partners SGRY | $3.53B | +100% | +2% | 13% | 77.2× | 15.6% |
| Tenet Healthcare THC | $21.6B | +45% | +6% | 17% | 13.4× | -1.4% |
| HCA Healthcare HCA | $99.5B | +20% | +6% | 15% | 15.6× | 3.1% |
| Universal Health Services UHS | $10.7B | +13% | +8% | 11% | 8.3× | -1.8% |
| Community Health Systems CYH | n/a | -34% | n/a | n/a | n/a | n/a |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | SGRY | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +74.0% | +1.7% | highest of 21 |
| 6-month return | +99.8% | -0.9% | highest of 21 |
| Distance from 52-week high | -1.0% | -18.4% | 2nd highest of 21 |
| Revenue growth (TTM) | +2.2% | +12.9% | 5th lowest of 21 |
| Operating margin | 12.8% | 9.4% | 8th highest of 21 |
| Forward P/E | 77.2× | 37.3× | 5th most expensive of 19 |
| Growth the price implies (Req g, 7 yrs) | 15.6% | 12.7% | 8th most demanding of 18 |
| Growth delivered (Del g) | +12.2% | +9.7% | 6th highest of 18 |
| Hurdle (Req g minus delivered) | +3.4 pp | +5.5 pp | 9th least demanding of 18 |
| ROIC minus cost of capital | -4.9 pp | -2.5 pp | 6th lowest of 21 |
| EV / EBITDA | 13.3× | 19.8× | 4th cheapest of 15 |
| Net debt / EBITDA | 4.9× | 3.3× | 7th most indebted of 17 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Surgery Partners SGRY | United States | $3.53B | +100% | +2% | 13% | 77.2× | 15.6% | +12.2% |
| Krishna Institute of Medical Sciences KIMS.NS | India | $3.41B | +2% | +35% | 11% | 81.9× | n/a | n/a |
| National HealthCare NHC | United States | $3.16B | +1% | +6% | 0% | n/a | 6.4% | +9.7% |
| Global Health MEDANTA.NS | India | $4.13B | +16% | +26% | 17% | 50.4× | n/a | n/a |
| Narayana Hrudayalaya NH.NS | India | $4.13B | 0% | +71% | 13% | 34.2× | 31.2% | +25.0% |
| Topchoice Medical 600763.SS | China | $2.33B | -12% | +7% | 26% | 24.8× | 12.4% | +6.9% |
| Brookdale Senior Living BKD | United States | $2.06B | -36% | -8% | 6% | 482.6× | 19.3% | -1.4% |
| Ardent Health ARDT | United States | $2.03B | +52% | +2% | 5% | 11.9× | -1.7% | +8.7% |
| Fortis Healthcare FORTIS.NS | India | $6.40B | -17% | +18% | 17% | 48.5× | 42.5% | +17.9% |
| Extendicare EXE.TO | Canada | $1.91B | -16% | +36% | 9% | 19.3× | 10.8% | +8.5% |
| Aster DM Quality Care ASTERDM.NS | India | $6.83B | -2% | +50% | 16% | 63.5× | 48.6% | -11.6% |
| Huaxia Eye Hospital 301267.SZ | China | $1.78B | -18% | +2% | 15% | 23.5× | 2.1% | +10.4% |
| Chemed CHE | United States | $7.12B | +24% | +5% | 14% | 20.2× | 3.3% | +4.0% |
| PACS PACS | United States | $7.35B | +25% | +11% | 8% | 17.5× | 7.5% | +29.7% |
| Sienna Senior Living SIA.TO | Canada | $1.58B | -8% | +15% | 10% | 40.9× | 18.9% | +8.6% |
| Ramsay Health Care RHC.AX | Australia | $8.31B | +41% | +4% | 5% | 31.4× | 14.0% | +8.3% |
| Xi'an International Medical Investment 000516.SZ | China | $1.46B | -2% | -1% | -2% | n/a | 12.7% | +20.6% |
| Aevis Victoria AEVS.SW | Switzerland | $1.43B | +8% | +15% | -6% | 106.8× | 26.5% | +10.2% |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.37B | -7% | +23% | 22% | 40.4× | 30.7% | +21.2% |
| Sanbo Hospital Management 301293.SZ | China | $1.35B | -29% | +17% | 6% | 135.5× | n/a | n/a |
| Spire Healthcare SPI.L | United Kingdom | $1.31B | +11% | +2% | 8% | 25.1× | 10.0% | +11.4% |